A role for oncostatin M in inflammatory bowel disease

Nature Medicine 23, 535 (2017). doi:10.1038/nm.4338 Authors: Walter M Kim, Arthur Kaser & Richard S Blumberg A new study identifies oncostatin M (OSM) as a potential biomarker and therapeutic target for anti-tumor necrosis factor (TNF)-refractory inflammatory bowel disease (IBD), and pinpoints mucosal stromal cells as key players in OSM-mediated inflammation.
Source: Nature Medicine - Category: Journals (General) Authors: Tags: News and Views Source Type: research